Table 4.
Supportive Care and Supplemental Treatments for Managing GI Disease in the Common Marmoset
| Drug | Dose | Comments |
|---|---|---|
| Bismuth subsalicylate | 5.25–10.5 mg PO q12-24 h | Gastroprotectant; decreases gut secretions and stool quantity |
| Budesonide | 0.25–0.75 mg PO q24h | Glucocorticoid for treatment of CLE/IBD/chronic malabsorption79 |
| Calcium citrate (powder) | 75 mg PO q24h | Recommended for animals diagnosed with moderate to severe GI malabsorption or animals with low calcium; calcium citrate has high bioavailability and can be mixed with food |
| Famotidine | 0.5–1 mg/kg PO, IM, IV q24h | GI protectant (H2 blocker); recommended peri-operatively and/or when appetite reduced |
| Maropitant | 1 mg/kg SC q24h | Antiemetic; recommended peri-operatively and/or when appetite reduced |
| Omeprazole | 0.5–1 mg/kg PO q24h | GI protectant (proton pump inhibitor); slower onset, but more efficacious than H2 blockers |
| Sucralfate | 100–200 mg/kg PO q12-24 h | Gastroprotectant; indicated for suspected ulcers |
| Vitamin D3 | 100–200 IU q24h or 500 IU 3×/wk or 400 IU EOD PO | Recommended for animals with chronic GI malabsorption (may note low calcium, phosphorous, and/or albumin on serum chemistry) |
| Yogurt/probiotic | 1 oz yogurt or probiotics as labeled PO q24h | Recommended for animals with chronic diarrhea or weight loss or suspected GI malabsorption |
CLE = chronic lymphocytic enteritis; EOD = every other day; GI = gastrointestinal; IBD = inflammatory bowel disease; IM = intramuscular; IU = international unit; IV = intravenous; PO = per os; SC = subcutaneous.